[Interferon-alpha in therapy of malignant hemoblastoses].
Schuler
M
M
Abteilung für Hämatologie, III. Medizinische Klinik und Poliklinik, Klinikum der Johannes-Gutenberg-Universität, Mainz.
Aulitzky
W E
WE
Schneller
F
F
Peschel
C
C
Huber
C
C
D003131:Combined Modality Therapy; D006801:Humans; D007943:Leukemia, Hairy Cell / Q000401:mortality / Q000628:therapy*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000401:mortality / Q000628:therapy*; D008223:Lymphoma / Q000401:mortality / Q000628:therapy*; D009101:Multiple Myeloma / Q000401:mortality / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate
Interferon-alpha in der Therapie maligner Hämoblastosen.